Insiders · Profile

Frenkel Ran

EVP, Chief Dev. Officer at Karyopharm Therapeutics. Filing since 6 Apr 2015. CIK 0001623108

Company

Date

Role

Action

Shares

Amount

Of holding

KPTI Karyopharm Therapeutics Inc.

28 Feb 2022

EVP, Chief Dev. Officer

Sold, plan not stated

1,663

$17.03K

1.0%

KPTI Karyopharm Therapeutics Inc.

17 Feb 2022

EVP, Chief Dev. Officer

Sold, plan not stated

2,929

$35.51K

2.8%

KPTI Karyopharm Therapeutics Inc.

7 Feb 2022

EVP, Chief Dev. Officer

Sold, plan not stated

1,991

$19.64K

1.9%

KPTI Karyopharm Therapeutics Inc.

18 Feb 2021

EVP, Chief Dev. Officer

Sold, plan not stated

2,887

$42.82K

5.9%

KPTI Karyopharm Therapeutics Inc.

11 Feb 2021

EVP, Chief Dev. Officer

Sold, plan not stated

2,046

$31.75K

4.9%

KPTI Karyopharm Therapeutics Inc.

7 May 2020

Chief Dev Operations Officer

Sold, plan not stated

1,974

$39.48K

5.3%

KPTI Karyopharm Therapeutics Inc.

19 Feb 2020

Chief Dev Operations Officer

Sold, plan not stated

2,975

$49.03K

7.6%

KPTI Karyopharm Therapeutics Inc.

7 Nov 2017

Chief Dev Operations Officer

Sold, plan not stated

4,958

$55.76K

16.7%

KPTI Karyopharm Therapeutics Inc.

14 Nov 2016

Chief Dev Operations Officer

Sold, plan not stated

3,309

$33.29K

18.4%

KPTI Karyopharm Therapeutics Inc.

7 Apr 2015

EVP, WW Development Operations

Bought

2,000

$66.00K

200%

KPTI Karyopharm Therapeutics Inc.

6 Apr 2015

EVP, WW Development Operations

Bought

1,000

$29.43K

opened

11 decisions on file.